Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
BMC Cancer
|
November 21, 2015
Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling
Bruno Christian Koehler, Adam Jassowicz, Anna-Lena Scherr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2004
Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer
Salah-Eddin Al-Batran, Akin Atmaca, Susanna Hegewisch-Becker, et al.
Journal of Cancer Research and Clinical Oncology
|
April 20, 2022
Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment
Leonidas Apostolidis, Kristin Lang, Leila Sisic, et al.
Cancer Research
|
July 4, 2018
High-Throughput Screening of Combinatorial Immunotherapies with Patient-Specific <i>In Silico</i> Models of Metastatic Colorectal Cancer
Jakob Nikolas Kather, Pornpimol Charoentong, Meggy Suarez-Carmona, et al.
Oncoimmunology
|
June 5, 2013
Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration
Niels Halama, Anna Spille, Tina Lerchl, et al.
Breast Cancer Research and Treatment
|
September 27, 2018
COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer
Katharina Smetanay, Philippe Junio, Manuel Feißt, et al.
Cancer Immunology, Immunotherapy : CII
|
May 24, 2006
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients
Alfred Zippelius, Asma Gati, Tammo Bartnick, et al.
Plos One
|
October 21, 2014
Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinoma
Stefan Welte, Toni Urbanik, Christin Elßner, et al.
Plos One
|
June 28, 2007
Real-time definition of non-randomness in the distribution of genomic events
Ulrich Abel, Annette Deichmann, Cynthia Bartholomae, et al.
The Journal of Clinical Investigation
|
October 8, 2009
Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma
Andreas Bonertz, Jürgen Weitz, Dong-Ho Kim Pietsch, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
BMC Cancer
|
November 21, 2015
Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling
Bruno Christian Koehler, Adam Jassowicz, Anna-Lena Scherr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2004
Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer
Salah-Eddin Al-Batran, Akin Atmaca, Susanna Hegewisch-Becker, et al.
Journal of Cancer Research and Clinical Oncology
|
April 20, 2022
Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment
Leonidas Apostolidis, Kristin Lang, Leila Sisic, et al.
Cancer Research
|
July 4, 2018
High-Throughput Screening of Combinatorial Immunotherapies with Patient-Specific <i>In Silico</i> Models of Metastatic Colorectal Cancer
Jakob Nikolas Kather, Pornpimol Charoentong, Meggy Suarez-Carmona, et al.
Oncoimmunology
|
June 5, 2013
Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration
Niels Halama, Anna Spille, Tina Lerchl, et al.
Breast Cancer Research and Treatment
|
September 27, 2018
COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer
Katharina Smetanay, Philippe Junio, Manuel Feißt, et al.
Cancer Immunology, Immunotherapy : CII
|
May 24, 2006
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients
Alfred Zippelius, Asma Gati, Tammo Bartnick, et al.
Plos One
|
October 21, 2014
Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinoma
Stefan Welte, Toni Urbanik, Christin Elßner, et al.
Plos One
|
June 28, 2007
Real-time definition of non-randomness in the distribution of genomic events
Ulrich Abel, Annette Deichmann, Cynthia Bartholomae, et al.
The Journal of Clinical Investigation
|
October 8, 2009
Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma
Andreas Bonertz, Jürgen Weitz, Dong-Ho Kim Pietsch, et al.
Page
of 6